{
  "nctId": "NCT04336631",
  "briefTitle": "DCP3 Based Multi-component Intervention for Hypertension Management and Control",
  "officialTitle": "Implementation of DCP3 Strategies to Manage and Control Hypertension Among Hypertensive Patients in Pakistan: A Randomized Controlled Trial",
  "protocolDocument": {
    "nctId": "NCT04336631",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2019-09-05",
    "uploadDate": "2020-04-01T17:34",
    "size": 956518,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04336631/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 500,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2019-11-01",
    "completionDate": "2020-03-30",
    "primaryCompletionDate": "2020-01-01",
    "firstSubmitDate": "2020-04-01",
    "firstPostDate": "2020-04-07"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* • Pakistani nationals both male and female of age 18 years and above will be invited to participate in the study\n\n  * Similarly; known hypertensive patients having a systolic blood pressure of ≥140 mmHg on current treatment will be included \\&\n  * Patients with co-morbidities will also be included such as those suffering from cardiac ailments (angina or transient ischemic attack (TIA) and diabetes\n\nExclusion Criteria:\n\n* • Patients with compromised neurological or cognitive state who are unable to provide their consent will be excluded\n\n  * Patients suffering from non-cardiovascular diseases and life-threatening illnesses such as angiographically proven coronary disease, peripheral or cerebral vascular disease, pulmonary hypertension, having history of myocardial infarction, stroke/PCI/stent or high-risk conditions will be excluded from participation\n  * Patients with chronic conditions and co-morbidities requiring surgical intervention or treatment such as cardiomyopathies or congenital abnormalities \\&\n  * Patients receiving dialysis will also be excluded from the study",
    "healthyVolunteers": true,
    "sex": "ALL",
    "stdAges": [
      "CHILD",
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of participants with adequate blood pressure control in the intervention arm after delivering the intervention at 03 months",
        "timeFrame": "03 months"
      },
      {
        "measure": "Number of participants with reduced salt intake from baseline measurements as compared to follow up measurements at 03 months",
        "description": "This was assessed at each consecutive follow up of hypertensive patients for reduced salt intake and increased physical exercise. Hypertensive patients were also counselled for regular intake of medicines prescribed by the physician. A record for the mentioned measurements was kept and maintained from baseline to 03 months of the trial.",
        "timeFrame": "Baseline to follow up in 03 months"
      },
      {
        "measure": "Number of participants with increased level of physical exercise compared from baseline measurements to follow up measurements at 03 months",
        "description": "This was assessed at each consecutive follow up of hypertensive patients for reduced salt intake and increased physical exercise. Hypertensive patients were also counselled for regular intake of medicines prescribed by the physician. A record for the mentioned measurements was kept and maintained from baseline to 03 months of the trial.",
        "timeFrame": "03 months"
      },
      {
        "measure": "Number of participants with regular compliance to medications from baseline measurement compared with follow up measurements at 03 months",
        "description": "This was assessed at each consecutive follow up of hypertensive patients for reduced salt intake and increased physical exercise. Hypertensive patients were also counselled for regular intake of medicines prescribed by the physician. A record for the mentioned measurements was kept and maintained from baseline to 03 months of the trial.",
        "timeFrame": "03 months"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 4,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 4
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 69,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:14.422Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}